Craneware (LON:CRW) Price Target Raised to GBX 2,900

Key Points

• Berenberg Bank raised the price target for Craneware from GBX 2,800 to GBX 2,900, indicating a potential upside of 25.54% from its current price.
• Shore Capital also reissued a "buy" rating while setting a price objective at GBX 2,650, contributing to an average target price of GBX 2,807.
• Craneware's stock performance shows a current price of GBX 2,310, with a market capitalization of £817.97 million and a P/E ratio of 5,435.29.

Craneware (LON:CRW - Get Free Report) had its target price hoisted by Berenberg Bank from GBX 2,800 to GBX 2,900 in a report released on Monday,Digital Look reports. The firm presently has a "buy" rating on the stock. Berenberg Bank's price target points to a potential upside of 25.54% from the stock's current price.

Separately, Shore Capital reissued a "buy" rating and issued a GBX 2,650 price objective on shares of Craneware in a research report on Wednesday, July 16th. Three research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company has an average rating of "Buy" and an average target price of GBX 2,807.

Craneware Stock Performance

LON:CRW opened at GBX 2,310 on Monday. The company has a debt-to-equity ratio of 12.22, a current ratio of 0.63 and a quick ratio of 1.00. The firm has a 50-day moving average of GBX 2,275.63 and a two-hundred day moving average of GBX 2,018.28. The stock has a market cap of £817.97 million, a P/E ratio of 5,435.29 and a beta of 0.28. Craneware has a 1-year low of GBX 1,330 and a 1-year high of GBX 2,580.

Craneware Company Profile

The Craneware Group, the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group's Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.